Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
45.1M
-
Shares change
-
-47.2M
-
Total reported value, excl. options
-
$59.5M
-
Value change
-
-$86M
-
Put/Call ratio
-
0
-
Number of buys
-
43
-
Number of sells
-
-45
-
Price
-
$1.32
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q2 2018
117 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q2 2018.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.1M shares
.
Largest 10 shareholders include BlackRock Inc. (10M shares), VANGUARD GROUP INC (7.96M shares), FMR LLC (3.92M shares), NATIXIS (3.44M shares), Artal Group S.A. (2.75M shares), MILLENNIUM MANAGEMENT LLC (2.54M shares), STATE STREET CORP (2.42M shares), NORTHERN TRUST CORP (1.78M shares), CAPSTONE INVESTMENT ADVISORS, LLC (707K shares), and Palo Alto Investors LP (616K shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.